Skip to main content
BIP logo

November 20, 2026

Internal newsletter of the Institut Pasteur

Institut Pasteur
  • Français
  • English
Press

Andes hantavirus: characterization of a rare disease cluster by coordinated genomic sequencing

In spring 2026, a cluster of hantavirus pulmonary syndrome cases emerged aboard the MV Hondius cruise ship during a transatlantic crossing from Argentina. The National Reference Center for Hantaviruses at the Institut Pasteur collaborated with key partners including: the Institute of Health Carlos III (Spain), Erasmus MC (Netherlands), the National Institute for Public Health and the Environment (Netherlands), the Institut Pasteur de Dakar (Senegal), the Icahn School of Medicine at Mount Sinai (United States), the University of Geneva (Switzerland), San Sebastián University (Chile), the National Institute for Communicable Diseases (South Africa), ANLIS-Malbrán (Argentina), the National Microbiology Laboratory of the Public Health Agency (Canada) and WHO to investigate this disease cluster with global implications, and published its findings in the journal Science. A total of 13 cases were identified in several countries, 12 of which were virologically confirmed through laboratory testing. Only the thirteenth case (the index case) remains a probable case. With three deaths reported among the confirmed cases, the case fatality rate is 25%. The identified causative agent is Andes virus (ANDV), an orthohantavirus endemic to Patagonia, Argentina and Chile, which remains the only documented hantavirus capable of human-to-human transmission. This study also demonstrates how a coordinated multinational genomic sequencing approach, combined with rigorous quality control, can be used to trace chains of transmission and avoid misinterpretation during outbreaks involving rare pathogens.

Find out more
 

<<< Retour
  • BIP Archives
  • Contact